CN102526509A - Medicine for treating hepatomegaly - Google Patents
Medicine for treating hepatomegaly Download PDFInfo
- Publication number
- CN102526509A CN102526509A CN2012100215466A CN201210021546A CN102526509A CN 102526509 A CN102526509 A CN 102526509A CN 2012100215466 A CN2012100215466 A CN 2012100215466A CN 201210021546 A CN201210021546 A CN 201210021546A CN 102526509 A CN102526509 A CN 102526509A
- Authority
- CN
- China
- Prior art keywords
- medicine
- hepatomegaly
- treating
- tablets
- medicine according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Landscapes
- Medicines Containing Plant Substances (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a medicine for treating hepatomegaly. The medicine for treating the hepatomegaly comprises the medicinal raw materials as follows: 7g of gastrodia elata, 7g of Rhizoma Pinelliae, 7g of taro pulp, 5g of pharbitis seed, 3g of garden burnet, 3g of Astragalus mongholicus, 5g of fructus psoraleae and 5g of date kernel; and the medicine for treating the hepatomegaly also comprises the components as follows: 20 furazolidone tablets, 20 terramycin tablets, 15 compound acetylsalicylic acid tablets, 2 belladonna tablets and 5 flu-treating capsules. The medicine for treating the hepatomegaly has the advantages that the medicine for treating the hepatomegaly can treat hepatomegaly caused by various reasons, has an obvious therapeutic effect and takes effect quickly; and through combined therapy of the traditional Chinese medicine and Western medicine, the used Western medicinal raw materials are finished medicines sold in the market, with wide source, easy obtainment and low price, so that the medicine for treating the hepatomegaly is low in cost and high in cost performance.
Description
Technical field
The present invention relates to a kind of medicine of treating hepatomegaly.
Background technology
Hepatomegaly is a kind of commonly encountered diseases; Pathogenic factor mainly is divided into infectious hepatomegaly and non-infectious hepatomegaly; That the source of infection of infectious hepatomegaly mainly contains is viral, chlamydia, rickettsia, antibacterial, spirillum, fungus, protozoon, anthelmintic, and non-viral infects and mainly contains toxic, congestion property, cholestasis property, dysbolismus property, liver cirrhosis, tumor and cyst etc.
Treat hepatomegaly at present, main Therapeutic Method is to understand its pathogenesis earlier, suits the remedy to the case then; But sometimes hepatomegaly is the omen of some disease, if can not in time treat, and might delay treatment; And if pathogenesis misjudge; The medication that might lead to errors loses the best opportunity of treatment, thereby causes serious consequence.
Summary of the invention
Untimely in order to solve above treatment hepatomegaly, need find the problem that the cause of disease could medication, the invention provides a kind of medicine that can effectively treat the hepatomegaly that the various causes of disease cause.
The present invention realizes through following measure:
A kind of medicine of treating hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g.
Described medicine, also contain following composition:
20 of furazolidone sheets, 20 of hydroxytetracycline tablets, 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
The furazolidone sheet is the commercially available finished medicines that can buy, and a lot of tame medicine enterprise production are arranged, and specification mainly contains 10mg, 30mg or 100mg, can use in medicine of the present invention.
Hydroxytetracycline tablet is the commercially available finished medicines that can buy, and a lot of tame medicine enterprise production are arranged, and specification mainly contains 0.125g or 0.25g, can use in medicine of the present invention.
Phenacetin+caffeine+aspirin is the commercially available finished medicines that can buy, and a lot of tame medicine enterprise production are arranged, and every contains aspirin 0.22g, phenacetin 0.15g, caffeine 35mg.
Contain 10 milligrams of Semen daturae extractums in the Semen daturae tablet, Semen daturae extractum is the extractum that Herba Belladonnae is processed into through ethanol extraction, and extractive technique also has been existing mature technique.
The cold relief capsule component is: every contains acetaminophen 250mg, amantadine hydrochloride 100mg, artificial Calculus Bovis 10mg, caffeine 15mg, chlorphenamine maleate 2mg.
Described medicine is processed pill.
Rhizoma Gastrodiae: endogenous wind stopping relieving convulsion, suppressing the hyperactive liver and subsiding YANG, dispelling wind and removing obstruction in the collateral.
Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens): the removing dampness spleen invigorating, antidiarrheal helps digestion.
Taro meat: the meat of Fructus Colocasiae Esculentae, the sweet suffering of Fructus Colocasiae Esculentae nature and flavor, flat.Has the QI invigorating kidney tonifying, the effect of removing blood stasis eliminating stagnation.
Semen Pharbitidis: the removing water retention by purgation relieving constipation, drink is washed in expectorant, and parasite killing is attacked long-pending.
Radix Sanguisorbae: cooling blood for hemostasis, heat-clearing and toxic substances removing, skin ulcer is held back in detumescence.
The Radix Astragali: invigorating QI to consolidate the body surface resistance, diuretic detumescent, expelling pus and toxin by strengthening QI, granulation promoting.
Fructus Psoraleae: be the fruit of legumes psoraleae.Reinforcing the kidney and supporting YANG; Helping inspiration to relieve asthma; Warming spleen and stopping diarrha.
Semen Ziziphi Spinosae: nourish heart, calm the nerves, arresting sweating.
Beneficial effect of the present invention: can treat the hepatomegaly that the various causes of disease cause, therapeutic effect is obvious, instant effect; Adopt therapy of combining Chinese and Western medicine, used Western medicine raw material is commercially available finished medicines, and wide material sources obtain easily, and low price, make that medicine of the present invention is with low cost, and cost performance is high.
The specific embodiment
For a better understanding of the present invention, further specify below in conjunction with specific embodiment.
Embodiment 1:
A kind of medicine of treating hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g.
Method for preparing: each crude drug was crushed to 80 mesh sieves, adds binding agent and process 10 pills.
Embodiment 2:
A kind of medicine of treating hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g,
20 of furazolidone sheets (10mg/sheet), 20 of hydroxytetracycline tablets (0.125g/ sheet), 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
Method for preparing: each crude drug was crushed to 80 mesh sieves, adds binding agent and process 10 pills.
Embodiment 3:
A kind of medicine of treating hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g,
20 of furazolidone sheets (30mg/sheet), 20 of hydroxytetracycline tablets (0.125g/ sheet), 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
Method for preparing: each crude drug was crushed to 80 mesh sieves, adds binding agent and process 10 pills.
Embodiment 4:
A kind of medicine of treating hepatomegaly, crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g,
20 of furazolidone sheets (100mg/sheet), 20 of hydroxytetracycline tablets (0.25g/ sheet), 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
Method for preparing: each crude drug was crushed to 80 mesh sieves, adds binding agent and process 10 pills.
The clinical effectiveness experiment:
Gathering patient examination has case 36 examples of hepatomegaly symptom, and wherein 16 examples are owing to hepatitis causes, 5 examples are caused that by liver abscess 11 examples are caused that by fatty liver 4 examples are caused by liver cirrhosis.36 routine patient's clinical symptoms all reach the clinical criterion of hepatomegaly.
36 routine patients are divided into 4 groups, use the medicine of the foregoing description 1-4 preparation to treat respectively,
Wherein contain the hepatomegaly patient that 4 examples are caused by hepatitis, the hepatomegaly that 2 examples are caused by liver abscess, the hepatomegaly that 2 examples are caused by fatty liver, the hepatomegaly that 1 example is caused by liver cirrhosis in 1 group;
Contain the hepatomegaly patient that 4 examples are caused by hepatitis in 2 groups, the hepatomegaly that 1 example is caused by liver abscess, the hepatomegaly that 3 examples are caused by fatty liver, the hepatomegaly that 1 example is caused by liver cirrhosis;
Contain the hepatomegaly patient that 4 examples are caused by hepatitis in 3 groups, the hepatomegaly that 1 example is caused by liver abscess, the hepatomegaly that 3 examples are caused by fatty liver, the hepatomegaly that 1 example is caused by liver cirrhosis;
Contain the hepatomegaly patient that 4 examples are caused by hepatitis in 4 groups, the hepatomegaly that 1 example is caused by liver abscess, the hepatomegaly that 3 examples are caused by fatty liver, the hepatomegaly that 1 example is caused by liver cirrhosis.
1 group of patient only treats according to the Therapeutic Method of treatment disease itself as matched group, does not take medicine to hepatomegaly specially; 2,3,4 groups of patients take the bolus of drug of embodiment 1,2,4 preparations respectively except treating with 1 group of the same Therapeutic Method according to treatment disease itself, and administrated method is to take every day twice; Each half; 7 days is a course of treatment, takes two courses of treatment altogether, observe the curative effect.
The hepatomegaly curative effect determinate standard:
Recovery from illness: hepatomegaly transference cure;
Effectively: the hepatomegaly symptom alleviates to some extent, but not recovery from illness;
Invalid: the hepatomegaly symptom does not have and alleviates.
4 groups of patient treatment situation statistical tables see the following form.
Can find out that by last table medicine of the present invention has better curative effect aspect the treatment hepatomegaly, and the medicine of embodiment 2 and 4 preparations is better than the therapeutic effect of the medicine of embodiment 1 preparation.
Typical case's example
1, Wang, the woman, 61 years old, the liver lower edge was not touched under the costal margin of patient right side, tenderness, shiver with cold hyperpyrexia, upper right abdomen pain, diagnostic result is a hepatitis B, and with hepatomegaly.When using the treatment hepatitis B medicine, take the medicine of treatment hepatomegaly of the present invention, take a course of treatment after; Tenderness is clearly better, and after two courses of treatment, the hepatomegaly transference cure is found in inspection; Inspired the confidence of patient's rehabilitation greatly; The positive partner treatment of back patient, the state of an illness is controlled, and leaves hospital smoothly.
2, grandson, the man, 29 years old, the violent and pain of persistence in hepatic region changed or cough aggravates with position, is liver abscess after diagnosing, and the hepatomegaly symptom is very serious.The patient takes medicine of the present invention in the medicine that uses the treatment liver abscess, take a course of treatment after, the hepatomegaly symptom obviously alleviates, liver abscess also obviously alleviates.Take medicine after two courses of treatment, liver abscess is fully recovered, the hepatomegaly recovery from illness.
Claims (8)
1. medicine of treating hepatomegaly is characterized in that crude drug contains following composition:
Rhizoma Gastrodiae 7g, Rhizoma Pinelliae (processed with Rhizoma Zingiberis Recens) 7g, taro meat 7g, Semen Pharbitidis 5g, Radix Sanguisorbae 3g, Radix Astragali 3g, Fructus Psoraleae 5g, Semen Ziziphi Spinosae 5g.
2. medicine according to claim 1 is characterized in that also containing following composition:
20 of furazolidone sheets, 20 of hydroxytetracycline tablets, 15 of phenacetin+caffeine+aspirins, 2 of Semen daturae tablets, 5 of cold relief capsules.
3. medicine according to claim 2 is characterized in that the furazolidone sheet is the specification of 10mg, 30mg or 100mg.
4. medicine according to claim 2 is characterized in that the hydroxytetracycline tablet specification is 0.125g or 0.25g.
5. medicine according to claim 2 is characterized in that phenacetin+caffeine+aspirin, and every contains aspirin 0.22g, phenacetin 0.15g, caffeine 35mg.
6. medicine according to claim 2 is characterized in that containing in the Semen daturae tablet 10 milligrams of Semen daturae extractums.
7. medicine according to claim 2, it is characterized in that the cold relief capsule component is: every contains acetaminophen 250mg, amantadine hydrochloride 100mg, artificial Calculus Bovis 10mg, caffeine 15mg, chlorphenamine maleate 2mg.
8. medicine according to claim 1 and 2 is characterized in that processing pill.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100215466A CN102526509B (en) | 2012-01-31 | 2012-01-31 | Medicine for treating hepatomegaly |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2012100215466A CN102526509B (en) | 2012-01-31 | 2012-01-31 | Medicine for treating hepatomegaly |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102526509A true CN102526509A (en) | 2012-07-04 |
| CN102526509B CN102526509B (en) | 2013-12-04 |
Family
ID=46335329
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2012100215466A Expired - Fee Related CN102526509B (en) | 2012-01-31 | 2012-01-31 | Medicine for treating hepatomegaly |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102526509B (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751547A (en) * | 2014-01-21 | 2014-04-30 | 四川绿禾药业有限公司 | Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof |
| CN106177760A (en) * | 2016-07-30 | 2016-12-07 | 陈国礼 | A kind of medicine treating hepatomegaly and preparation method |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1216703A (en) * | 1997-12-23 | 1999-05-19 | 李伟 | Medicine for treating enterogastric disease |
| CN1443557A (en) * | 2003-02-10 | 2003-09-24 | 裴艳锋 | Yigante capsule for curing hepatitis B |
| CN1943779A (en) * | 2006-11-07 | 2007-04-11 | 闫敬武 | The processing method of bupleurum root preparation and its application |
| CN101204532A (en) * | 2007-12-19 | 2008-06-25 | 孙义岭 | Medicine for prostate disease and preparation method thereof |
| CN101301364A (en) * | 2008-06-19 | 2008-11-12 | 池晓玲 | Externally used Chinese medicine for treating cirrhosis ascites and preparation thereof |
| CN102114211A (en) * | 2010-11-26 | 2011-07-06 | 易国松 | Chinese herbal medicine for treating hepatopathy |
-
2012
- 2012-01-31 CN CN2012100215466A patent/CN102526509B/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1216703A (en) * | 1997-12-23 | 1999-05-19 | 李伟 | Medicine for treating enterogastric disease |
| CN1443557A (en) * | 2003-02-10 | 2003-09-24 | 裴艳锋 | Yigante capsule for curing hepatitis B |
| CN1943779A (en) * | 2006-11-07 | 2007-04-11 | 闫敬武 | The processing method of bupleurum root preparation and its application |
| CN101204532A (en) * | 2007-12-19 | 2008-06-25 | 孙义岭 | Medicine for prostate disease and preparation method thereof |
| CN101301364A (en) * | 2008-06-19 | 2008-11-12 | 池晓玲 | Externally used Chinese medicine for treating cirrhosis ascites and preparation thereof |
| CN102114211A (en) * | 2010-11-26 | 2011-07-06 | 易国松 | Chinese herbal medicine for treating hepatopathy |
Non-Patent Citations (8)
| Title |
|---|
| 南京中医药大学编著: "《中药大辞典》", 31 March 2006, article "《芋头》", pages: 1153-1154 * |
| 国家药典委员会: "《国家药品标准 新药转正标准.第54册》", 31 December 2006, article "感冒胶囊", pages: 54-55 - 54-56 * |
| 尚清秀等: "《肝肿大》", 《社区医学杂志》, vol. 5, no. 24, 20 December 2007 (2007-12-20), pages 21 - 22 * |
| 常怡勇: "颠茄片", 《中国医药报》, 29 April 2008 (2008-04-29), pages 07 * |
| 战志华等: "《中医治疗水肿药物配伍规律的研究》", 《承德医学院学报》, vol. 22, no. 1, 30 March 2005 (2005-03-30), pages 34 - 38 * |
| 杨跃辉: "抗感冒药的现状分析", 《中国药事》, vol. 23, no. 12, 20 December 2009 (2009-12-20), pages 1224 - 1227 * |
| 白秋江 等: "中成药中所含西药成分状况的调查与思考", 《中成药》, vol. 29, no. 5, 20 May 2007 (2007-05-20), pages 741 - 743 * |
| 蔡志春: "抗感冒药的合理应用", 《中国社区医师》, vol. 23, no. 9, 1 May 2007 (2007-05-01), pages 14 - 16 * |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103751547A (en) * | 2014-01-21 | 2014-04-30 | 四川绿禾药业有限公司 | Traditional Chinese medicinal composition for reducing blood lipid and preparation method thereof |
| CN106177760A (en) * | 2016-07-30 | 2016-12-07 | 陈国礼 | A kind of medicine treating hepatomegaly and preparation method |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102526509B (en) | 2013-12-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN103386022B (en) | Chinese medicine composition for treating tuberculous pleurisy | |
| CN104826016B (en) | A kind of pharmaceutical composition and its preparation method and application for treating the proliferation of mammary gland | |
| CN114306206B (en) | External traditional Chinese medicine composition for treating thyroid nodule and preparation method and application of external traditional Chinese medicine gel plaster | |
| CN103830632A (en) | Chinese traditional medicine preparation for radically treating psoriasis and multiple skin diseases and preparation method and application thereof | |
| CN105381132A (en) | Drug for treating thyroid nodule | |
| CN102657736B (en) | Medicament composition for treating rheumatoid arthritis and preparation method of medicament composition | |
| CN102091268A (en) | Medicament for treating allergic rhinitis and preparation method thereof | |
| CN102526509B (en) | Medicine for treating hepatomegaly | |
| CN105434972A (en) | Traditional Chinese medicine composition for treating breast hyperplasia | |
| CN104436145A (en) | Pharmaceutical composition for preventing and/or treating allergic rhinitis and allergic asthma | |
| CN104548008A (en) | Pharmaceutical composition for preventing and/or treating allergic skin diseases and preparation method for pharmaceutical composition | |
| CN104337989A (en) | Traditional Chinese medicine composition containing centipeda minima and frankincense for treating gout | |
| CN104435567A (en) | Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout | |
| CN103599204B (en) | Chinese medicine composition and its preparation method and application | |
| CN101732469B (en) | Application of Chinese medicinal composition in preparation of medicament for treating aphonia | |
| CN104147270A (en) | Traditional Chinese medicine for treating acute hepatitis | |
| CN102225155B (en) | Medicament composition for treating pulmonary fibrosis | |
| WO2016127771A1 (en) | Application of 20(r)-ginsenoside rg3 in preparing drug or healthcare product for alleviating or/and treating rheumatoid disease and drug containing 20(r)-ginsenoside rg3 | |
| CN110841007B (en) | Traditional Chinese medicine composition for treating cerebral apoplexy sequela and application thereof | |
| CN101695534B (en) | Chinese patent medicament for treating mammary gland disease | |
| CN110215474B (en) | Traditional Chinese medicine composition for promoting blood circulation to remove blood stasis and application thereof | |
| CN102406790A (en) | Traditional Chinese medicine capsule for treating hyperplasia of mammary glands and preparation method thereof | |
| CN101732539B (en) | Medicament for treating gynecological diseases and preparation method thereof | |
| CN101007113A (en) | Shenling Chinese medicine preparation for treating acute and chronic hepatitis and its preparation method | |
| CN105687659A (en) | Medicine patch for treating cesarean-postoperative abdominal incision sclerosis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20131204 Termination date: 20150131 |
|
| EXPY | Termination of patent right or utility model |